4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-003681
Chief Commercial Officer sold 10,000 shares at $46.00 ($460,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Weinberg Eric Chief Commercial Officer | 2024-01-09 | Sale 10b5-1 | −10,000 | $46.00 | $460,000 | 319,978 | I: show line 1 in the form |
| Open-market sales · 10,000 sh · avg $46.00 · $460,000 | |||||||
Loading xslF345X05/ownership.xml…